-+ 0.00%
-+ 0.00%
-+ 0.00%

Pomdoctor Intends To Accelerate Related Technology Research And Development Adoption Through Its Medical Resources And Strong Compliance Capabilities

Benzinga·03/13/2026 12:14:05
Listen to the news

Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track of "artificial intelligence ("AI") + medical-grade smart wearables + full-cycle chronic disease management".

The Company plans to accelerate related technology research and development ("R&D") and scenario-based implementation by leveraging its extensive medical resources and strong compliance capabilities. Over the long run, Pomdoctor aims to build a closed-loop chronic disease management ecosystem integrating hardware, data, algorithms and services, expanding the Company's long-term growth horizon while delivering sustained medical value to patients.